Free Trial
Patrick R. Trucchio

Patrick R. Trucchio Analyst Performance

Biotechnology Analyst at HC Wainwright

Patrick R. Trucchio is a stock analyst at HC Wainwright in the medical sector, covering 9 publicly traded companies. Over the past year, Patrick R. Trucchio has issued 10 stock ratings, including and buy recommendations. While full access to Patrick R. Trucchio's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Patrick R. Trucchio's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
10 Last 0 Years
Buy Recommendations
100.00% 10 Buy Ratings
Companies Covered
9 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy100.0%10 ratings
Hold0.0%0 ratings
Sell0.0%0 ratings

the majority (100.0%) have been Buy recommendations.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
88.9% of companies on NASDAQ
8 companies
NYSE
11.1% of companies on NYSE
1 company

Patrick R. Trucchio, an analyst at HC Wainwright, currently covers 9 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
9 companies
100.0%

Patrick R. Trucchio of HC Wainwright specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
8 companies
88.9%
MED - DRUGS
1 company
11.1%

About Patrick R. Trucchio

Mr. Trucchio is a Managing Director of Equity Research at H.C. Wainwright whose research focuses on biotechnology, specifically on inflammation, fibrosis, cardio-metabolic, CNS, and rare diseases in addition to other areas. Mr. Trucchio has thirteen years of research experience on the sell-side. Prior to joining H.C. Wainwright, Mr. Trucchio was a senior equity research analyst at Berenberg Capital Markets (BCM) covering biotechnology and specialty pharmaceutical companies. Prior to Berenberg Capital Markets, Mr. Trucchio worked at Wells Fargo Securities and BMO Capital Markets. At Wells Fargo, Mr Trucchio worked on an Institutional Investor ranked analyst team covering specialty pharmaceutical companies. Mr. Trucchio’s educational background includes an M.B.A. with Honors from St. John’s University and a B.S. in Finance from The Pennsylvania State University.
Follow on LinkedIn

Patrick R. Trucchio's Ratings History at HC Wainwright

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Aligos Therapeutics, Inc. stock logo
ALGS
Aligos Therapeutics
9/12/2025Reiterated Rating$10.31$50.00Buy
NRx Pharmaceuticals, Inc. stock logo
NRXP
NRx Pharmaceuticals
9/8/2025Initiated Coverage$2.75$40.00Buy
uniQure N.V. stock logo
QURE
uniQure
9/5/2025Reiterated Rating$17.56$70.00Buy
Sangamo Therapeutics, Inc. stock logo
SGMO
Sangamo Therapeutics
9/4/2025Reiterated Rating$0.53$10.00Buy
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
9/2/2025Reiterated Rating$446.87$570.00Buy
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
9/2/2025Reiterated Rating$24.88$80.00Buy
Invivyd, Inc. stock logo
IVVD
Invivyd
8/27/2025Reiterated Rating$1.03$5.00Buy
Bright Minds Biosciences Inc. stock logo
DRUG
Bright Minds Biosciences
8/19/2025Reiterated Rating$42.25$85.00Buy
Aligos Therapeutics, Inc. stock logo
ALGS
Aligos Therapeutics
8/18/2025Initiated Coverage$7.70$50.00Buy
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
8/18/2025Reiterated Rating$3.30$10.00Buy